Intravenous injection of hapten-conjugated syngeneic cells results in specific immunological tolerance affecting both hapten-specific contact sensitivity and plaqueforming cell responses (1-4) . Although the underlying basis for this nonresponsiveness is not fully understood, it appears that both the T-and B-cell compartments may be affected (3-5) . In addition, several studies have reported the generation of specific suppressor T cells under these conditions (4-6).
Intravenous injection of hapten-conjugated syngeneic cells results in specific immunological tolerance affecting both hapten-specific contact sensitivity and plaqueforming cell responses (1) (2) (3) (4) . Although the underlying basis for this nonresponsiveness is not fully understood, it appears that both the T-and B-cell compartments may be affected (3) (4) (5) . In addition, several studies have reported the generation of specific suppressor T cells under these conditions (4) (5) (6) .
The antigen that was used to induce specific nonresponsiveness (suppression) in these studies was the synthetic linear polypeptide of L-glutamic acid, L-lysine and Lphenylalanine (GLO).1 This antigen was chosen for several reasons . (a) The immune response to GL4 is under histocompatibility-linked immune response gene control (7) . (b) Although previous attempts to identify GLO specific suppressor T cells in nonresponder mice have been unsuccessful (8, 9) , we questioned whether induction with antigen-modified syngeneic cells would be a more efficient means of inducing T suppressor cells. (c) In addition, we sought to provide evidence that nonresponder mice could generate functional T cells with specificity for GLO .
To date, all systems that analyzed nonresponsiveness induced with antigen-modified syngeneic cells employed small, chemically reactive molecules which were covalently conjugated to cell surface proteins . In the present study, we have used a different method of coupling antigen to spleen cells . This new coupling method uses the ability of palmitoyl-derivatized polypeptides to adhere to cell membranes . Thus, polypeptides can be coupled onto spleen cells without excessive chemical modification of the peptide and without the formation of covalent bonds between the polypeptide antigens and any cell surface molecules . We now demonstrate that the intravenous administration of syngeneic spleen cells modified with a palmitoyl-derivatized polypeptide results in antigen-specific nonresponsiveness and the induction of specific suppressor T cells.
Materials and Methods
Mice. C57BL/6 male mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. All experimental animals were between 8 and 12 wk of age at the beginning of immunization . Animals were age matched in each experiment .
Antigen. The linear terpolymers~oly-(L-Glu 56-L-Lys35-L-Phe), GL4, lot GLPl, average mol wt 38,000, and poly-(L-Glu 6o-L-Lys" , GL, lot L641, average mol wt 40,000 were prepared by Miles Yeda, Ltd., Rehovot, Israel . Fowl gamma globulin (FyG) was purchased from Miles Laboratories, Inc., Elkhart, Ind. GL4o-FyG and GL-FyG were synthesized with the Schiff base method (10) . The GLO-FyG or GL-FyG conjugates along with unreacted FyG were separated from the unreacted GLO or GL with 45 or 100% saturated ammonium sulfate respectively, and then dialyzed extensively in phosphate-buffered saline (PBS) .
Immunization . Mice were immunized i.p . in a volume of 0.2 ml with 20#g of GLO conjugated to FyG. The adjuvant was a mixture of 1% Maalox and 25% pertussis vaccine (M/P) . Maalox was purchased from William H. Rorer, .Inc ., Fort Washington, Pa . and pertussis vaccine was purchased from Eli Lilly and Co ., Indianapolis, Ind.
Palmitoyl-GLO. The palmitoyl derivative of GLO (p-GLO) was synthesized by the method of Cheung et al . (10) . Trace amounts of palmitoyl-GL 1126 were used to estimate the amount of antigen bound per cell (10) .
Induction of Suppression . Twice-washed single spleen cell suspensions were pelleted and resuspended in 1 mg/ml p-GLO in PBS. 2 F,1 of the p-GLO solution was used for every 106 spleen cells. Control cells were incubated in PBS instead of p-GLO. After incubation at 37°C for 30 min, the cells were twice washed in minimal essential medium (MEM) containing 0.3% heparin. After they were washed, the cells were resuspended to 6 X 10 7 cells/ml, and 0.5-m1 quantities were injected per mouse, i.v .
Adoptive Transfer. 5 days after being primed with p-GL0-coupled spleen cells, mice were sacrificed, the recipient spleens were teased in sterile MEM with 0.3% heparin, and the cells were washed twice and resuspended in heparinized MEM for i.v . injection into normal recipients . These recipient mice were then immediately challenged with 20 ug GLO-FyG in Maalox and pertussis adjuvant i.p ., and the GL0 and FyG-specific spleen plaque-forming cells (PFC) assayed 8 days afterwards .
Anti-Thy-I Treatment. 10 s suppressor spleen cells from p-GLO-cell primed mice were pelleted and incubated with 0.5 ml of a 1:2 dilution of AKR anti-C3H thymocyte serum or normal mouse serum as control. After 30 min at 20°C the serum was removed and 0.5 ml rabbit complement diluted 1 :5 was added in L-15 medium with 1% DNase for a 30-min incubation at 37°C and the cells were resuspended in the same media for i .v. injection.
Cyclophosphamide Treatment. Cyclophosphamide (Cytoxan) was purchased from Mead Johnson & Co ., Evansville, Ind. The drug was administered intraperitoneally in the dose of 5 mg/kg. 2 days after cytoxan treatment, 3 X 107 p-GL0-coupled spleen cells (p-GL0-spl cells) were injected i.v. to induce tolerance.
PFCAssay. The antibody responses to GLO-FyG and GL-FyG were enumerated 7 or 8 days after immunization by a modification of theJerne hemolytic plaque technique (10) . GLO-sheep erythrocytes (SRBC) or GL-SRBC were prepared with respective palmitoyl conjugates (10) . FyG-SRBC were prepared by incubating a chicken anti-SRBC antiserum with washed SRBC at 37°C for 30 min (9) . A goat anti-,u antiserum provided by Dr . R. Asofsky, National Institutes of Health, Bethesda, Md . was used to inhibit IgM PFC, and a rabbit anti-mouse IgG was used to develop IgG PFC. Only PFC that were inhibitable with 25-50 ug per slide of free ligand were reported as antigen-specific plaques. Generally, 95-100% PFCs are specifically inhibitable . All results are expressed as PFC per spleen . The cell recovery per spleen did not vary significantly between groups .
Statistical Analysis. All data were analyzed for significance by using a two-tailed Student's t test, performed on a Wang 700 calculator (Wang Laboratories, Inc., Lowell, Mass .) .
Results
G4-Specific Nonresponsiveness . When appropriate quantities of p-GL4 were injected i.v . into C57BL/6 mice, GLO-specific nonresponsiveness was induced (Table I ) . In the (Table I) ; however, there was no reduction of the FyG response (vide infra) . In contrast, no significant tolerance was noted when 1 lag of p-GL4 was used as pretreatment . In separate experiments 10 ng to 1 Ag doses of soluble p-GLO also failed to affect the GL.O-specific PFC response, whereas 10-NLg doses were again tolerogenic (data not shown) . It was likely that hydrophobic molecules such as p-GL4 reacted with both serum proteins and cells . However, because the cell-bound antigen may be more effective in producing nonresponsiveness, the next experiment was carried out to elucidate the importance of cell surface-associated GL4 molecules (Table I) . Mice were injected with 107 GL.p-coupled syngeneic spleen cells (p-GLO-spl cells) or with 107 control spleen cells. 3 days later they were immunized with 20 ltg G14-FyG in M/P (day 0) . 8 days later their spleens were assayed for GLO PFC responses . In mice that received p-GL.0-spl, both the IgM and IgG anti-GLcp responses were decreased by 70-80%, compared with mice that received control cells . The efficiency of cell surface-associated GLqS in the induction of tolerance was evident from the trace labeling studies. The data indicated that 0 . 1-Ftg quantities of GL4 were carried by the 107 p-GL.~-spl cells able to induce tolerance, whereas, as demonstrated above, 0.01-1-g,g quantities of p-GL4 (when administered i.v. as the soluble form) were not able to decrease the GL4 PFC response to G14-FyG (Table I) .
To demonstrate that the decrease in the GL4 PFC response on day 8 after immunization was not the result of a shift in the appearance of the peak of the antibody response, the PFC responses of the tolerized mice were analyzed at various days after immunization . As shown in Fig . 1 A, day 8 after immunization was the peak of the PFC response for both control and tolerant mice. Moreover, the immune response of the tolerant mice remained significantly diminished throughout the period of day 6 to day 12. This tolerance is GL4 specific, because the anti-FyG PFC response was not affected (Fig. 1 B) . Furthermore, the PFC response to trinitrophenyl-keyhole limpet hemocyanin or horse erythrocytes was not decreased in mice that were given an i.v. injection of GLO spleen cells, confirming the specificity of the p-GLq~-splinduced nonresponsiveness (data not shown) .
Fine Specificity of GL4 Nonresponsiveness. We have previously demonstrated that the antibody responses to GLO and GL are highly cross-reactive (7) and that these antibodies share idiotypic determinants (11) . Therefore, we tested the fine specificity ofGLcp nonresponsiveness with the cross-reacting polymer GL. Nonresponsiveness was induced in C57BL/6 mice with GL.0,-palmitoyl-coupled syngeneic cells. 3 days after induction, mice were challenged with either G14-FyG or GL-FyG. As shown in Table  11 , the GL,0-and GL-specific PFC responses were significantly reduced, while the FyG-PFC responses were not affected. Thus, the effector mechanism (s) which mediate this tolerance can not distinguish between the closely related cross-reactive polypeptides GL and GLO . TABLE 11 Fine Specificity of GL4 Tolerance * C57BL/6 mice were given 3 X 107 GL¢ coupled spleen cells, i .v ., 3 days before challenge with 20 Wg GL40-FyG or GL-FyG. Animals were sacrificed 8 days after challenge for PFC assay. $ Arithmetic mean of PFC response t SE ; three to four mice are included in each group . § Indicates P < 0 .02 . Dose Requirements for Induction of Nonresponsiveness . To establish the optimal dose of p-GLO-spl cells used for tolerance induction, C57BL/6 mice were injected with 2 X 104 to 3 X 10' p-GL4-spl cells, while control groups received equivalent numbers of normal spleen cells. 3 days later, the mice were immunized with 20 Itg GLO-FyG in M/P (day 0) and their spleens were assayed on day 8. The degree of tolerance in the experimental mice was expressed as percent reduction of the control PFC response. As shown in Fig. 2 , there was a dose dependence for tolerance induction by p-GI.4-spl . At least 2 X 105 cells were required for optimal reduction of both IgM and IgG responses . Trace labeling studies revealed that -2 ng GLO was carried on 2 X 105 p-GL(to-spl cells.
Kinetics of Tolerance Induction. The time required for the development of nonresponsiveness and the tolerant state was next investigated. C57BL/6 mice were treated with 3 X 107 p-GLO-spl cells i.v., while control groups were given 3 X 107 normal spleen cells. As shown in Fig . 3 , groups of mice were immunized with 20 Ftg GLO-FyG in M/P at various times after receiving control or GL.~-coupled spleen cells, and their spleens were assayed 8 days later. Under optimal conditions G14-specific IgM and IgG responses were decreased by 80-90% of control responses . The induction of nonresponsiveness required a latent period (1-2 days before challenge) and the state of tolerance lasted for at least 63 days after injection.
p-GLO-spl Cells Induce GL4-Specific Suppressor Cells. Since these antigen modified cells induced such a strong state of nonresponsiveness lasting at least 2 mo, an active suppressor mechanism was considered to be involved. Two transfer experiments were performed in which similar results were obtained in each experiment . Donor animals were sacrificed 5 days after tolerance induction with p-GLO-spl and their spleen cells were transferred into normal syngeneic recipients . Control mice received an equal number of normal spleen cells. All mice were immediately challenged with 20 lig GL.¢-FyG in M/P and 8 days later their spleens were assayed . 2 X 107 viable spleen cells from p-GLO-spl-treated donors led to significant (60-70%, P < 0.01) suppression in the recipient animals (Table III) . The treatment of such suppressor spleen cells with anti-Thy 1 .2 serum plus complement (C) but not with normal mouse serum (NMS) plus C before transfer removed the suppressive activity (Table III) . Thus, the suppression of GLO responses is a T-cell-dependent process .
Induction hosphamide sensitive in other systems (l2, 13) we have analyzed the phamide sensitivity of the GLO-specific <57BL/8mice were rocsaline Lp 2 days before suppression induction cells. Control mice were given cyclophosphamide 'xsaline 2 days before in injection of 3X \07 normal spleen cells . These nice were then challenged with 2OAg G1.0-F}G in M/P and their spleens were assayed on day 8. As shown iuTable IV ' suppression could ont 6cdemonstrated iot6e cycop6nop6aooide-po,treutodgronpgi~eap'C;l^O-spiI6uo,t6ngeomrabooofuouremponxiveneaoiut6in system is vnoikive tusmall doses of cyclop6oop6arui6m . ' 5 days after suppressor cell induction, 2 X 10 7 spleen cells from tolerant or control groups were transferred into normal recipients . Tolerant cells were also treated with either NMS plus C or anti-Thy 1 .2 serum plus C before transfer into normal recipients. All mice were then challenged with 20 pg GL~-FyG in M/P. Spleen cells were assayed 8 days later for PFC . $ Arithmetic mean PFC response t SE. § Indicates P < 0 .01 . 
Discussion
The present experiments demonstrate the striking efficiency of cell surface-associated GLO in inducing a long-lasting state of nonresponsiveness . The intravenous administration of 2 X 106 to 3 X 107 p-GLO-spl cells carrying 1-100 ng inhibits the primary GLO-specific IgM and IgG PFC responses . This state of nonresponsiveness lasts at least 63 days. Although the response to the closely related, serologically crossreactive polymer GL is also inhibited, the nonresponsiveness is antigen specific, because the PFC response to the FyG carrier is not affected. Suppressor cells appear to be responsible for initiating and (or) maintaining this state of tolerance, because spleen cells from tolerant mice can transfer tolerance to normal recipients. Moreover, the induction of nonresponsiveness is cyclophosphamide sensitive and the cells which can transfer suppression are Thy 1 .2 positive. The phenomenon we have described contrasts with the state of "low zone" tolerance described by Dresser and Mitchison (14) and Rajewsky and Brenig (15) . The induction of low zone tolerance required repeated injection ofsubimmunogeneic concentrations of antigen over a prolonged period of time. In contrast, GLO-specific tolerance was rapidly induced (<3 days) after a single intravenous administration of tolerogen . Furthermore, in the present studies, nanogram quantities of soluble p-GLO failed to induce suppression unless the p-GLO was associated with cells .
The adoptive transfer experiments clearly demonstrated that Thy 1 .2-positive cells from tolerant mice were required to specifically suppress the GLO antibody response in normal recipients. Antigen carryover cannot account for the ability to adoptively transfer suppression, because p-GLO-spl cells administered on the day of immunization with GL0-FyG could not decrease the day 8 GL4 PFC response. In addition, cyclophosphamide treatment, which has been shown to interfere with the process of suppressor cell induction (12, 13) , abrogates the induction of GL(O tolerance . Thus, from these various experiments it appears that suppressor T cells are required for the generation of G14-specific nonresponsiveness induced with p-GLO-spl cells.
It is well established that haptenated syngeneic cells can be used to specifically suppress a hapten-specific PFC response (3, 4) or contact sensitivity reaction (1, 2) . The most commonly used haptens for these studies have been trinitrophenyl and dinitrophenyl . The induction of hapten-specific T-cell tolerance by the i.v. administration of nitrophenylated syngeneic cells is at least in part mediated by Thy 1-positive suppressor cells (4) (5) (6) . Furthermore, the induction of trinitrophenyl-specific suppressor T cells was demonstrated to be cyclophosphamide sensitive (16) . The results presented in this report closely parallel those noted in the hapten systems, in that small numbers of antigen-coupled cells are sufficient to induce a potent, longlasting T-cell-dependent suppression . However, unlike the chemical conjugation methods that covalently couple hapten to cell surface proteins, the palmitoyl coupling method does not covalently associate GL4 with any cell surface molecules . We believe that the palmitoyl-derivatized peptides are anchored into the lipid portion of the membrane and may be presented to the immune system in the same form as a foreign minor histocompatibility determinant . The palmitoyl coupling method should prove generally applicable to other lysine-containing peptides and proteins . Indeed, initial experiments have indicated that proteins can be coupled to syngeneic cells to induce specific suppression .
The route of administration of antigen-modified syngeneic cells may be crucial in the induction of suppression . In other systems, the i.v. administration of modified syngeneic cells appears to be the most efficient route for the induction of suppressor cells (1) (2) (3) 17) . Experiments are in progress to define (a) the importance of the route of antigen administration, (b) the cell type(s) that are most efficient in the induction of suppression, and (c) the nature of the cell surface molecules that provide the induction signals.
C57BL/6 mice are genetic nonresponders to GLcp by virtue of the fact that they lack an H-linked Ir gene which is required for GLO responsiveness (7) . The genetic defect in GLO nonresponder mice appears to function at the level of the induction of GLO-specific helper T cells . Thus, C57BL/6 nonresponder mice produce anti-GLO antibody, after immunization with GLO that has been conjugated to an immunogenic carrier, such as FyG (10) , indicating that nonresponder mice do not have a defect in their B-cell repertoire. Hence, the GLO polypeptide may function as a "hapten" in C57BL/6 nonresponder mice, and as a result the many similarities between the suppression induced with antigen-modified cells in the hapten and GL¢, systems may not be coincidental.
The mechanism(s) of GLO-specific suppression are under investigation . Several possible mechanisms can be considered at this time. First, the GL.O suppressor cells may act directly upon GL4t0 or GL helper T cells . In opposition to this possibility are the data from various systems, which indicate C57BL/6 nonresponder mice do not produce helper cells to these polypeptides (18, 19) . A second possibility, which has been suggested previously (3) and which may apply here, is that the GL0 suppressor cells act directly on the GI-0-or GL-specific PFC precursor cells . This mechanism could also explain the lack of fine specificity with respect to GL4 and GL, since This report represents the first indication that GL4 nonresponder mice possess functional T cells with specificity for GLO, and suggests that GL¢ nonresponder animals can generate a T-cell receptor with specificity for this polymer. Heretofore, the data have suggested that nonresponder mice lacked helper and suppressor T cells (8, 18, 19) . Transferable T-cell-mediated suppression was not previously demonstrated in GLO nonresponder mice (9) . The present experiments demonstrate that GL(~- 
